The company intends to use the proceeds to purchase established, cash-generative healthcare businesses that can provide immediate earnings and bolster its international distribution network. By deploying capital through its financing subsidiary, Davion Healthcare Finance Ltd, the group will grant security over the specific assets acquired with these funds. CEO Jack Kaye noted that the firm is already evaluating several potential targets, emphasizing a disciplined approach to pricing and integration. The bond, which began trading in August 2026, serves as a key pillar in the company’s broader plan to evolve into a larger, more diversified international entity. While the listing provides a new financing channel, the company clarified that the admission does not confirm the full subscription of the £30 million principal amount. The move reflects Davion's ongoing transition from a technology developer to a multifaceted healthcare group with a global footprint.
In section Releases
Davion Healthcare Lists £30 Million Bond on Vienna MTF
Dublin-based Davion Healthcare has officially listed a £30 million senior secured bond on the Vienna MTF, securing fresh capital to fuel an aggressive acquisition strategy. The five-year instrument, carrying a 10.5% annual coupon, aims to accelerate the group’s expansion into medical devices, diagnostics, and healthcare services.
Comments (0)
No comments yet. Be the first!